Onychomysosis
☆ AI Dermatology — Free Service
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Toenail affectus Onychomycosis (Onychomycosis)
Pes hominis cum infectione fungali unguium decem hebdomades in cursu medicamenti terbinafine oralis. Nota vitta sanæ incrementi ungui post reliquas ungues infectas.
relevance score : -100.0%
ReferencesAntifungalia systemica curatio efficacissima sunt. Meta‑analyses curarum mycoticarum rates ostendit hoc modo: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole =48% . Concomitantia clavi debridementa rates curationis amplius augent. Terapia topica cum ciclopirox minus efficax est; habet ratem defectus superans 60%.
Systemic antifungals are the most effective treatment. Meta-analyses shows mycotic cure rates as follows: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole =48%. Concomitant nail debridement further increases cure rates. Topical therapy with ciclopirox is less effective; it has a failure rate exceeding 60%.
Systemic antifungals are the most effective treatment. Meta-analyses shows mycotic cure rates as follows: terbinafine = 76%, itraconazole with pulse dosing = 63%, itraconazole with continuous dosing = 59%, fluconazole =48%. Concomitant nail debridement further increases cure rates. Topical therapy with ciclopirox is less effective; it has a failure rate exceeding 60%.
Onychomycosis est infectio fungalis quae ungues afficit. Cum a dermatophytis causatur, tinea unguium vocatur. Onychomycosis includit infectiones a dermatophytis, fermentis et mouldibus causatas. Unguis non causatus ex contagione fungali dicitur dystrophia unguis. Tametsi afficere ungues manus et pedis potest, onychomycosis unguis pedis communior est. Hic articulus varias rationes onychomycis unguis pedis discutit, ut de eius impulso, generibus clinicis, gradibus, diagnosi et curatione. Quamquam non est vita minata, onychomycosis gravis complicationes potest ducere, sicut cellulitis, sepsis, osteomyelitis, damnum textus, et damnum unguis.
Onychomycosis is a fungal infection of the nail unit. When dermatophytes cause onychomycosis, this condition is called tinea unguium. The term onychomycosis encompasses the dermatophytes, yeasts, and saprophytic mold infections. An abnormal nail not caused by a fungal infection is a dystrophic nail. Onychomycosis can infect both fingernails and toenails, but onychomycosis of the toenail is much more prevalent. Discussed in detail in this activity are all evolving facets of the topic, including disease burden, clinical types, staging, diagnosis, and management of toenail onychomycosis. While non-life-threatening, onychomycosis can lead to severe complications such as cellulitis, sepsis, osteomyelitis, tissue damage, and nail loss.
Onychomycosis is a fungal infection of the nail unit. When dermatophytes cause onychomycosis, this condition is called tinea unguium. The term onychomycosis encompasses the dermatophytes, yeasts, and saprophytic mold infections. An abnormal nail not caused by a fungal infection is a dystrophic nail. Onychomycosis can infect both fingernails and toenails, but onychomycosis of the toenail is much more prevalent. Discussed in detail in this activity are all evolving facets of the topic, including disease burden, clinical types, staging, diagnosis, and management of toenail onychomycosis. While non-life-threatening, onychomycosis can lead to severe complications such as cellulitis, sepsis, osteomyelitis, tissue damage, and nail loss.
Terbinafine medicamentum est, quod infectiones fungales pugnat, inhibitione epoxidasi squalenae. Efficax est contra plerosque dermatophyta (dermatophytes) et approbatur ad usum oralis in curatione onychomycis (onychomycosis). Plurimae effectus laterales leves et auto‑limitantes sunt, sicut cephalalgia (headache) et symptomata gastrointestinalia (gastrointestinal symptoms); mutationes gustus (dysgeusia) variari possunt a levi ad gravem, interdum ad pondus amissum ducens. Mutationes gustus permanentes rarae sunt, sed occasionaliter relatae sunt.
Terbinafine is an antifungal medication that works through the inhibition of squalene epoxidase. It has activity against most dermatophytes, and it has approval for use as an oral therapy for the treatment of onychomycosis. Although most side effects are mild and self-limited, such as headache and gastrointestinal symptoms, taste disturbances (dysgeusia) can range from mild to severe, resulting in weight loss, and have rarely been reported permanent.
Terbinafine is an antifungal medication that works through the inhibition of squalene epoxidase. It has activity against most dermatophytes, and it has approval for use as an oral therapy for the treatment of onychomycosis. Although most side effects are mild and self-limited, such as headache and gastrointestinal symptoms, taste disturbances (dysgeusia) can range from mild to severe, resulting in weight loss, and have rarely been reported permanent.
Onychomycosis est infectio fungalis quae ungues afficit. Circa 90% infectionum ungues pedis et 75% infectionum ungues manus a fungis causantur (Trichophyton mentagrophytes, Trichophyton rubrum). Indicia includunt unguis coloratus, crassitudinem, separationem unguis a culmine, et excrescentiam. Curatio typice involvit medicamentum orale sicut terbinafina vel itraconazolum, cum curationibus topicis in casibus moderatis.
Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis.
Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis.
Medicamentum antifungale terbinafine ore sumtum efficacissimum esse videtur, sed terbinafine effectus laterales hepatis coniungitur.
Onychomycosis occurs in circiter 10 centesimis incolarum adultorum, cum maioribus natu frequentius afficitur. Viri (men) saepius afficiuntur quam feminae. Onychomycosis repraesentat circiter dimidium morborum ungularum. Hoc significat deformitatem unguium etiam ex aliis causis quam onychomycosis venire.
○ Curatio OTC Medicamenta
Difficile est onychomycosim cum medicamentis topicis tractare, quia difficile est medicamentis incrassatis unguibus penetrare.
#Ketoconazole
#Clotrimazole
#Miconazole
#Terbinafine
#Butenafine [Lotrimin]
#Tolnaftate
○ Curatio
Longum tempus curatio requiri solet donec unguiculatum infectis penitus tollatur.
#Terbinafine (oral)
#Itraconazole
#Efinaconazole lacquer [Jublia]
#Ciclopirox lacquer